American Society For Transplantation And Cellular Therapy | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Headlines Articles Press releases American Society For Transplantation And Cellular Therapy

Home
Companies
American Society For Transplantation And Cellular Therapy

BRIEF

published on 04/10/2024 at 16:05, 7 months 10 days ago

ASTCT Endorses FDA's New CAR T-Cell Therapy Approvals for Multiple Myeloma

FDA Approval Medical Innovation Multiple Myeloma CAR T-cell Therapy ASTCT Endorsement
PRESS RELEASE

published on 04/10/2024 at 16:00, 7 months 10 days ago

ASTCT Supports the FDA's Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
FDA approves expanded use of CAR T-Cell therapies Abecma and Carvykti for multiple myeloma treatment, supported by ASTCT. Decision based on FDA and ODAC recommendations

FDA Approval Multiple Myeloma CAR T-cell Therapy ASTCT Support Disease Intervention
BRIEF

published on 03/22/2024 at 16:05, 7 months 29 days ago

Medicare étend la couverture des greffes de cellules souches pour les syndromes myélodysplasiques

Transplantation De Cellules Souches Assurance-maladie Syndromes Myélodysplasiques Détermination De La Couverture Nationale Politique De Santé
BRIEF

published on 03/22/2024 at 16:05, 7 months 29 days ago

Medicare Expands Stem Cell Transplant Coverage for Myelodysplastic Syndromes

Medicare Stem Cell Transplantation Health Policy Myelodysplastic Syndromes National Coverage Determination
PRESS RELEASE

published on 03/22/2024 at 16:00, 7 months 29 days ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
CMS revises National Coverage Determination for allogeneic HSCT in MDS patients following requests from ASH, ASTCT, NMDP, and CIBMTR. Updated ruling expands Medicare coverage for life-saving treatment

National Coverage Determination CMS Allogeneic HSCT MDS Patients Medicare Coverage
PRESS RELEASE

published on 02/27/2024 at 17:00, 8 months 22 days ago

Corey Cutler, MD, MPH Named 2024-2025 President of ASTCT
Corey Cutler, MD, MPH appointed as President of ASTCT for 2024-2025 term. Dr. Cutler aims to advance science and education for the transplant community. Learn more about the ASTCT Board of Directors

Board Of Directors President ASTCT Transplantation Corey Cutler
BRIEF

published on 02/27/2024 at 17:00, 8 months 22 days ago

Corey Cutler Named ASTCT President for 2024-2025

ASTCT Medical Research Corey Cutler Educational Science Stem Cell Transplantation
BRIEF

published on 02/27/2024 at 17:00, 8 months 22 days ago

Corey Cutler Nommé Président de l'ASTCT pour 2024-2025

ASTCT Recherche Médicale Corey Cutler Transplantation De Cellules Souches Educational Science
PRESS RELEASE

published on 02/22/2024 at 22:00, 8 months 27 days ago

ASTCT to Present Distinguished Honors at the 2024 Tandem Meetings
ASTCT presents top awards to leaders in transplantation and cellular therapy at the Tandem Meetings in San Antonio. Dr. Gerard Socie receives the 2024 Lifetime Achievement Award for his research on Graft-versus-host disease

Cellular Therapy Tandem Meetings ASTCT Transplantation Award Winners
BRIEF

published on 02/22/2024 at 22:00, 8 months 27 days ago

Leaders in Transplantation and Cellular Therapy Honored by ASTCT

Cellular Therapy Research ASTCT Transplantation Awards

Accesswire

Published on 11/21/2024 at 12:00, 56 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 56 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 26 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 53 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 56 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 21 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 41 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 50 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 56 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 26 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 58 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 49 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 36 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE